Antipsychotic cyclic N-aralkylamines

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S217030, C540S484000, C540S596000, C540S609000

Reexamination Certificate

active

06908914

ABSTRACT:
The invention relates to benzene derivatives, to pharmaceutical compositions containing them, to processes for preparing them, and to the method of use thereof in the treatment of psychotic disorders.

REFERENCES:
patent: 5231092 (1993-07-01), Lavastre et al.
patent: 5296596 (1994-03-01), Lavastre et al.
patent: 6235791 (2001-05-01), Breliere et al.
patent: 0461986 (1991-12-01), None
patent: 2159369 (1973-06-01), None
patent: WO 89/12443 (1989-12-01), None
patent: WO 95/30659 (1995-11-01), None
patent: WO 98/04251 (1998-02-01), None
Chemical Abstract No. 118:2375 (1993).
Chemical Abstract No. 119:130911 (1983).
Chemical Abstract No. 83:97373 (1975).
Zhang, M. Q. et al., J. Pharm. Pharmacol., vol. 45, No. 1, pp. 63-66 (1993).
Zhang, M. Q. et al., Chirality, US, vol. 6, No. 8, pp. 631-641 (1994).
Reitz, Allen B. et al., J. Med.Chem., vol. 41, No. 12, pp. 1997-2009 (1998).
Derwent Patent Abstract No. 197322 (2001).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antipsychotic cyclic N-aralkylamines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antipsychotic cyclic N-aralkylamines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antipsychotic cyclic N-aralkylamines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3516763

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.